Catalyst Commends FasterCures for Highlighting FDA Resource Needs
As the Trump transition team forms its plans for taking the reins in January, Catalyst applauds FasterCures for issuing a set of recommendations intended to inform the new Administration’s approach to biomedical research and FDA. As one of 150 thought leaders interviewed for the group’s “Rx for Innovation” report, I’m happy to see the recommendations